Login or sign up
For business
Average ratingGreat
4.1/ 5

Based on 13 reviews

538%
431%
331%
20%
10%
Ask AI

Ask AI about Pharmaxis

Generated with AI from 13 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Pharmaxis

Pharmaxis Ltd (ACN 082 811 630) is a specialist pharmaceutical company involved in the research, development and
commercialization of therapeutic products for chronic respiratory disorders. Its product Aridol® forthe assessment of asthma issold in key international markets. Its product Bronchitol® for cystic fibrosis is recently launched in Europe and Australia and its development pipeline of productsincludes, Bronchitol for bronchiectasis, PXS64 forthe treatment of lung fibrosis, ASM8 for asthma and PXS4728 for fibrotic disease. Pharmaxisislisted on the Australian Securities Exchange (symbol PXS). The company’s head office and manufacturing facilities are located in Sydney.

Categories
Pharmaceuticals